Girotec 25 mg / 50 mg / 100 mg / 200 mg TABLETS
PDF Leaflet Revision Date: 21/09/2021
Clinical Summary
Quick overview from the medicine insert
Indication
Monotherapy or add-on treatment for epilepsy and bipolar disorder.
Dosage (summary)
Adults: Initial 25 mg daily, increase to 100-200 mg. Children: 0.6 mg/kg/day.
Onset of Action / Duration
Onset: 1.4 to 4.8 hours, Duration: 25 hours.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Valproic acid increases half-life
- Enzyme inducers decrease half-life
Contraindications
- Hypersensitivity to lamotrigine
- Renal impairment
- Hepatic impairment
- Pregnancy
- Lactation
Common side effects
- Headache
- Dizziness
- Nausea
- Skin rash
- Fatigue
Counselling Points
- Avoid abrupt withdrawal
- Monitor for rashes
- Consult if symptoms worsen
Serious warnings
- Risk of severe skin reactions
- Monitor for hypersensitivity
- Risk of seizures on abrupt withdrawal
Important Disclaimer
The Girotec 25 mg / 50 mg / 100 mg / 200 mg TABLETS professional information leaflet below is the property of Aurobindo Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
